Dr. Cinti earned her Biological Science degree (University of Bologna) in 1984. She is board certified in Genetics and obtained a postdoctoral NATO Senior Fellowship in Biotechnology and Molecular Biology at the Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, USA, in 1993. She has been a senior scientist researcher at the National Research Council (CNR) of Italy since 1994 and was a member of the S.H.O. team at the Jefferson Medical College, Thomas Jefferson University, from 1994 to 2002. She was an Adjunct Associate Professor at the College of Science and Biotechnology of Temple University, Philadelphia, USA, from 2002 to 2005. She was the tutor of several doctoral and undergraduate students and supervisor of master’s and PhD theses (1997 to 2018). From 2006 to 2018, she was Director of the CNR Operative Unit of Institute of Clinical Physiology (IFC), Department of Biomedicine, in Siena. At the end of 2018, Dr. Cinti moved to the Institute of Organic Synthesis and Photoreactivity (ISOF), Department of Chemical Sciences and Materials Technologies of the CNR. From 2016 to present, she is a member of the Executive Committee of International Consortium for Personalized Medicine (ICPerMed). Her research activities focus on the field of biomedical research: in particular, the development of novel therapeutic solutions, including drug delivery systems, with the aim to design and set up personalized therapeutic strategies for pathologies with high social impact.
Dr. Cinti earned her Biological Science degree (University of Bologna) in 1984. She is board certified in Genetics and obtained a postdoctoral NATO Senior Fellowship in Biotechnology and Molecular Biology at the Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, USA, in 1993. She has been a senior scientist researcher at the National Research Council (CNR) of Italy since 1994 and was a member of the S.H.O. team at the Jefferson Medical College, Thomas Jefferson University, from 1994 to 2002. She was an Adjunct Associate Professor at the College of Science and Biotechnology of Temple University, Philadelphia, USA, from 2002 to 2005. She was the tutor of several doctoral and undergraduate students and supervisor of master’s and PhD theses (1997 to 2018). From 2006 to 2018, she was Director of the CNR Operative Unit of Institute of Clinical Physiology (IFC), Department of Biomedicine, in Siena. At the end of 2018, Dr. Cinti moved to the Institute of Organic Synthesis and Photoreactivity (ISOF), Department of Chemical Sciences and Materials Technologies of the CNR. From 2016 to present, she is a member of the Executive Committee of International Consortium for Personalized Medicine (ICPerMed). Her research activities focus on the field of biomedical research: in particular, the development of novel therapeutic solutions, including drug delivery systems, with the aim to design and set up personalized therapeutic strategies for pathologies with high social impact.